By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today reported fourth-quarter 2011 results that beat analyst estimates on the top and bottom line.

For the period ended Dec. 31, the firm posted net sales of $521.4 million, up 8 percent from $483.6 million a year ago and surpassing Wall Street expectations of $516.9 million.

Organically, sales were up 8 percent for the quarter, President and CEO Douglas Berthiaum said during a conference call following the release of Waters' results.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.